Fourth, IKKβ‐USP30 (ubiquitin‐specific peptidase 30)‐ACLY axis, which is a novel tumor cell regulatory axis, was recently identified to be upregulated in HCC [94]. Here, ACLY is linked to hepatocellular carcinoma.